Your browser doesn't support javascript.
loading
Preclinical findings predicting efficacy and side-effect profile of LY2940094, an antagonist of nociceptin receptors.
Witkin, Jeffrey M; Rorick-Kehn, Linda M; Benvenga, Mark J; Adams, Benjamin L; Gleason, Scott D; Knitowski, Karen M; Li, Xia; Chaney, Steven; Falcone, Julie F; Smith, Janice W; Foss, Julie; Lloyd, Kirsti; Catlow, John T; McKinzie, David L; Svensson, Kjell A; Barth, Vanessa N; Toledo, Miguel A; Diaz, Nuria; Lafuente, Celia; Jiménez, Alma; Benito, Alfonso; Pedregal, Conception; Martínez-Grau, Maria A; Post, Anke; Ansonoff, Michael A; Pintar, John E; Statnick, Michael A.
Afiliação
  • Witkin JM; Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana.
  • Rorick-Kehn LM; Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana.
  • Benvenga MJ; Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana.
  • Adams BL; Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana.
  • Gleason SD; Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana.
  • Knitowski KM; Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana.
  • Li X; Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana.
  • Chaney S; Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana.
  • Falcone JF; Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana.
  • Smith JW; Lilly Research Laboratories Eli Lilly and Company Windlesham Surrey United Kingdom.
  • Foss J; Lilly Research Laboratories Eli Lilly and Company Windlesham Surrey United Kingdom.
  • Lloyd K; Lilly Research Laboratories Eli Lilly and Company Windlesham Surrey United Kingdom.
  • Catlow JT; Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana.
  • McKinzie DL; Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana.
  • Svensson KA; Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana.
  • Barth VN; Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana.
  • Toledo MA; Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana; Lilly Research Laboratories Eli Lilly and Company Alcobendas Madrid Spain.
  • Diaz N; Lilly Research Laboratories Eli Lilly and Company Alcobendas Madrid Spain.
  • Lafuente C; Lilly Research Laboratories Eli Lilly and Company Alcobendas Madrid Spain.
  • Jiménez A; Lilly Research Laboratories Eli Lilly and Company Alcobendas Madrid Spain.
  • Benito A; Lilly Research Laboratories Eli Lilly and Company Alcobendas Madrid Spain.
  • Pedregal C; Lilly Research Laboratories Eli Lilly and Company Alcobendas Madrid Spain.
  • Martínez-Grau MA; Lilly Research Laboratories Eli Lilly and Company Alcobendas Madrid Spain.
  • Post A; Lilly Research Laboratories Eli Lilly and Company Windlesham Surrey United Kingdom.
  • Ansonoff MA; Lilly Research Laboratories Eli Lilly and Company Rutgers-Robert Wood Johnson Medical School New Brunswick New Jersey.
  • Pintar JE; Lilly Research Laboratories Eli Lilly and Company Rutgers-Robert Wood Johnson Medical School New Brunswick New Jersey.
  • Statnick MA; Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana.
Pharmacol Res Perspect ; 4(6): e00275, 2016 12.
Article em En | MEDLINE | ID: mdl-28097008
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article